Skip to main content
. 2020 Sep 3;34(5):2667–2673. doi: 10.21873/invivo.12086

Table II. Comparison between patients with and without disease control (DC).

graphic file with name in_vivo-34-2669-i0001.jpg

ECOG PS: Eastern Corporative Oncology Group performance status; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; LMR: lymphocyte-to-monocyte ratio. Bold values indicate statistical significance.